Prologue Medicines

Prologue Medicines is designing powerful new drugs by unraveling the viral proteome. The company's most advanced DELVE™ platform systematically identifies and evaluates viral proteins and their unique functions to determine their potential for precisely modulating human physiology. By collaborating with viral evolution, Prologue Medicines is expanding the functional boundaries of human genome-encoded proteins to create new programmable medicines.